Medica RCP |Oxaliplatin Hospira 100mg | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Oxaliplatin Hospira 100mg

Contraindicated
Reproductive toxicity in animals

Contraindicated
Manque de données

Oxaliplatin Hospira 100mg :
Type	Medicine Authorised
Originator	Eloxatine 100mg*
Agent	Food & Drug Corporation
Distributor	Food & Drug Corporation
Laboratory	Hospira
Responsible Party	Hospira UK Ltd
Origin	UK
Manufacturer	Hospira UK Limited
Manufacturing Type	G
Origin	UK
ATC	L01XA03

Oxaliplatin Hospira 100mg :

Injectable

Intravenous

Oxaliplatin Hospira 100mg :

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01X Other antineoplastic agents

L01XA Platinum compounds

L01XA03 Oxaliplatin

Oxaliplatin Hospira 100mg :

Oxaliplatin : 5mg/ml

Oxaliplatin Hospira 100mg :

Adults : Colon cancer stage III 85mg/m² every 2 weeks

Adults : Metastatic colorectal cancer 85mg/m² every 2 weeks

Oxaliplatin Hospira 100mg :

Povidone 30

Tartaric acid (E334)

Water for injections

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Oxaliplatin Hospira 100mg :

Revision Date : 20/01/2017

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Abdominal pain	Very Common
Allergic reaction	Very Common
Allergy	Very Common
Alopecia	Very Common
Anaemia	Very Common
Anorexia	Very Common
Arthralgia (Pain joint) (Joint ache)	Common
Asthenia	Very Common
Back pain	Very Common
Blindness transient (Temporary vision loss)	Rare
Blood alkaline phosphatase increased	Very Common
Blood lactate dehydrogenase increased	Very Common
Bone pain	Common
Cephalea	Very Common
Colitis	Rare
Conjunctivitis	Common
Constipation	Very Common
Cough	Very Common
Creatinine increased	Common
Deafness	Rare
Deep vein thrombosis	Common
Dehydration	Common
Depression	Common
Diarrhoea (Diarrhea)	Very Common
Diarrhoea, Clostridium difficile	Rare
Dizzy spells	Common
Dysarthria	Rare
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance)	Very Common
Dyspepsia	Common
Dyspnoea (dyspnea)	Very Common
Dysuria (Micturition painful)	Common
Epistaxis (Nasal bleeding)	Very Common
Fatigue	Very Common
Febrile neutropenia (Neutropenic fever)	Common
Fever	Very Common
Flushing	Common
Gastrointestinal bleeding	Common
Gastrooesophageal reflux disease	Common
Haematuria (Hematuria)	Common
Haemolytic anemia	Rare
Haemorrhage	Common
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome)	Common
Hepatic enzyme increased	Very Common
Hiccups	Common
Hyperglycaemia	Very Common
Hyperhidrosis	Common
Hypernatraemia	Very Common
Hypertension	Common
Hypokalaemia	Very Common
Ileus	Uncommon
Immune-mediated thrombocytopenia	Rare
Infection	Very Common
Injection site reaction	Very Common
Insomnia	Common
Interstitial pneumonia	Rare
Intestinal obstruction	Uncommon
Leucopenia (Leukopenia)	Very Common
Lymphopenia	Very Common
Meningism	Common
Metabolic acidosis	Uncommon
Mucositis	Very Common
Nail disorders	Common
Nausea postoperative	Very Common
Nervousness	Uncommon
Neuritis motor	Common
Neutropenia	Very Common
Neutropenic sepsis	Common
Optic neuritis	Rare
Ototoxicity	Uncommon
Pain	Very Common
Pancreatitis	Rare
Peripheral sensory neuropathy	Very Common
Posterior reversible leukoencephalopathy syndrome (PRES)	Rare
Pulmonary embolism	Common
Pulmonary fibrosis	Rare
Rash erythematous	Common
Rectal haemorrhage	Common
Rhinitis	Common
Sensory disturbance	Very Common
Sepsis (Systemic infection) (Sepsis state)	Uncommon
Serum bilirubin increased	Very Common
Skin disorders	Very Common
Skin rash	Common
Stomatitis	Very Common
Thrombocytopenia (Thrombopenia)	Very Common
Upper respiratory tract infection	Common
Urinary frequency altered	Common
Visual acuity reduced	Rare
Visual disturbance	Common
Visual field defect	Rare
Vomiting	Very Common
Weight decreased (Weight loss)	Common
Weight increased (weight gain)	Very Common

Oxaliplatin Hospira 100mg :

Abu Dhabi

Cyprus

Czech Republic

Denmark

Finland

France

Greece

Iceland

Italy

Jordan

KSA

Lebanon

Norway

Oman

Spain

Sweden

The Netherlands

Turkey

UAE

Form	Concentrate for solution for infusion
Packaging	Bottle
Package Size	1x20ml
Strength	100mg
Public Price	8200847.91 L.L.
Stratum	C
NSSF	✔
Quarantine	✘
Reg. Number	219300/09
Submission date	01/01/2009
Registration Year	2010

Medicine Authorised

Avastin 100mg

Omnipharma

Roche

Medicine Authorised

Avastin 100mg²

Omnipharma

Roche

Medicine Authorised

Avastin 400mg

Omnipharma

Roche

Medicine Authorised

Avastin 400mg²

Omnipharma

Roche

Medicine Authorised

Bevacirel 100mg

Levant Pulse

Reliance Life Sciences

Medicine Authorised

Bevacirel 400mg

Levant Pulse

Reliance Life Sciences

Medicine Authorised

Bivastina 100mg

Benta Trading Co

JSC Biocad

Medicine Authorised

Bivastina 400mg

Benta Trading Co

JSC Biocad

Medicine Authorised

Campto 40mg

Food & Drug Corporation

Pfizer

Medicine Authorised

Eloxatine 50mg

Mersaco

Sanofi

Medicine Authorised

Erbitux 100mg/20ml

Food & Drug Corporation

Merck

Medicine Authorised

Geneplatin 100mg

Nobel Pharm Plus

Genepharm

Medicine Authorised

Geneplatin 50mg

Nobel Pharm Plus

Genepharm

Medicine Authorised

Irinogen

New Europharm

BioProfarma

Medicine Authorised

Irinogen²

New Europharm

BioProfarma

Medicine Authorised

Irinotecan GP-Pharm

Mediterranean Pharmaceutical Company

GP-Pharm

Medicine Authorised

Irinotecan Hospira 40mg

Food & Drug Corporation

Hospira

TAU

Irinotecan Sagent

Major Pharma Drugstore

Sagent

Medicine Authorised

Irinotecan Thymoorgan 100mg

Abela Freres

Hikma Pharmaceuticals

Medicine Authorised

Irinotecan Thymoorgan 40mg

Abela Freres

Hikma Pharmaceuticals